Neumora Therapeutics Inc (NMRA)

Nov 20, 2024

Neumora Therapeutics, Inc. (NMRA): This Small-Cap Stock Is Ready To Explode - MSN

Nov 20, 2024

Nov 20, 2024

This biotech’s stock could double if its treatment for major depressive disorder succeeds, says Mizuho - MSN

Nov 20, 2024

Nov 19, 2024

10 Best Small-Cap Stocks Ready To Explode - Insider Monkey

Nov 19, 2024

Nov 18, 2024

Financial Comparison: Neumora Therapeutics (NMRA) and Its Rivals - Defense World

Nov 18, 2024

Nov 16, 2024

HC Wainwright Issues Pessimistic Forecast for NMRA Earnings - Defense World

Nov 16, 2024

Nov 16, 2024

Analysts Set Neumora Therapeutics, Inc. (NASDAQ:NMRA) Target Price at $21.67 - Defense World

Nov 16, 2024

Nov 16, 2024

Equities Analysts Set Expectations for NMRA FY2024 Earnings - Defense World

Nov 16, 2024

Nov 15, 2024

FY2024 Earnings Forecast for NMRA Issued By William Blair - MarketBeat

Nov 15, 2024

Nov 15, 2024

HC Wainwright Analysts Lower Earnings Estimates for NMRA - MarketBeat

Nov 15, 2024

Nov 13, 2024

This biotech’s stock may double on treatment for depression, says Mizuho - MarketWatch

Nov 13, 2024

Nov 13, 2024

SoftBank Group Corp.'s Strategic Reduction in Neumora Therapeuti - GuruFocus.com

Nov 13, 2024

Nov 13, 2024

Neumora Therapeutics (NASDAQ:NMRA) Announces Earnings Results, Misses Estimates By $0.06 EPS - MarketBeat

Nov 13, 2024

Nov 13, 2024

Needham & Company LLC Reiterates Buy Rating for Neumora Therapeutics (NASDAQ:NMRA) - MarketBeat

Nov 13, 2024

Nov 13, 2024

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Receives $21.67 Average PT from Analysts - MarketBeat

Nov 13, 2024

Nov 12, 2024

Neumora Therapeutics Reports Q3 2024 Financial Results - TipRanks

Nov 12, 2024

Nov 12, 2024

Neumora Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 12, 2024

Nov 12, 2024

Neumora Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update - The Manila Times

Nov 12, 2024

Nov 12, 2024

Neumora Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire Inc.

Nov 12, 2024

Nov 11, 2024

Where Do Analysts Think The Neumora Therapeutics Inc (NASDAQ: NMRA) Is Going - Stocks Register

Nov 11, 2024

Nov 10, 2024

Neumora Therapeutics (NMRA) to Release Quarterly Earnings on Tuesday - Defense World

Nov 10, 2024

Nov 07, 2024

Objective long/short (NMRA) Report - Stock Traders Daily

Nov 07, 2024

Nov 06, 2024

Neumora Therapeutics downgraded to Neutral from Overweight at JPMorgan - MSN

Nov 06, 2024

Nov 06, 2024

What You Didn’t Know About Neumora Therapeutics Inc (NASDAQ: NMRA) This Week - Stocks Register

Nov 06, 2024

Nov 06, 2024

Neumora Therapeutics to Participate in Upcoming Conferences in November - The Manila Times

Nov 06, 2024

Nov 05, 2024

Neumora Therapeutics (NASDAQ:NMRA) Shares Gap DownHere's Why - MarketBeat

Nov 05, 2024

Nov 05, 2024

Neumora Therapeutics (NMRA) Set to Announce Quarterly Earnings on Tuesday - MarketBeat

Nov 05, 2024

Nov 05, 2024

Auour Investments LLC Takes $3.30 Million Position in Neumora Therapeutics, Inc. (NASDAQ:NMRA) - MarketBeat

Nov 05, 2024

Nov 05, 2024

This Cognex Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For TuesdayCognex (NASDAQ:CGNX) - Benzinga

Nov 05, 2024

Nov 05, 2024

Neumora Therapeutics (NASDAQ:NMRA) Downgraded by JPMorgan Chase & Co. to Neutral - MarketBeat

Nov 05, 2024

Nov 05, 2024

JPMorgan downgrades Neumora stock, warns of potential downside without data clarity - Investing.com UK

Nov 05, 2024

Oct 31, 2024

Critical Analysis: Neumora Therapeutics (NMRA) and The Competition - Defense World

Oct 31, 2024

Oct 29, 2024

Neumora Therapeutics to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024 - The Manila Times

Oct 29, 2024

Oct 27, 2024

(NMRA) On The My Stocks Page - Stock Traders Daily

Oct 27, 2024

Oct 25, 2024

Neumora Therapeutics (NASDAQ:NMRA) Trading Down 4.5%Time to Sell? - MarketBeat

Oct 25, 2024

Oct 23, 2024

Neumora Therapeutics (NASDAQ:NMRA) Sees Large Volume IncreaseTime to Buy? - MarketBeat

Oct 23, 2024

Oct 22, 2024

Neumora Therapeutics (NASDAQ:NMRA) Shares Gap Down Following Insider Selling - Defense World

Oct 22, 2024

Oct 21, 2024

SG Americas Securities LLC Lowers Holdings in Neumora Therapeutics, Inc. (NASDAQ:NMRA) - Defense World

Oct 21, 2024

Oct 21, 2024

Bleakley Financial Group LLC Sells 1,966 Shares of Vanguard Mid-Cap Growth ETF (NYSEARCA:VOT) - Defense World

Oct 21, 2024

Oct 21, 2024

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Shares Sold by SG Americas Securities LLC - MarketBeat

Oct 21, 2024

Oct 19, 2024

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Oct 19, 2024

Oct 18, 2024

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Director Sells $239,254.47 in Stock - MarketBeat

Oct 18, 2024

Oct 18, 2024

Neumora Therapeutics director Matthew Fust sells $370,961 in stock - Investing.com India

Oct 18, 2024

Oct 18, 2024

Neumora Therapeutics director Matthew Fust sells $370,961 in stock By Investing.com - Investing.com South Africa

Oct 18, 2024

Oct 18, 2024

Neumora Therapeutics (NASDAQ:NMRA) Rating Reiterated by Needham & Company LLC - MarketBeat

Oct 18, 2024

Oct 17, 2024

(NMRA) Investment Analysis - Stock Traders Daily

Oct 17, 2024

Oct 16, 2024

This trade activity should not be overlooked: Neumora Therapeutics Inc. (NMRA) - SETE News

Oct 16, 2024

Oct 16, 2024

Neumora Therapeutics: A Story Of A Class II Biotech (NASDAQ:NMRA) - Seeking Alpha

Oct 16, 2024

Oct 15, 2024

Neumora Therapeutics (NASDAQ:NMRA) Shares Gap Down After Insider Selling - Defense World

Oct 15, 2024

Oct 14, 2024

Have you been able to find a good deal on Neumora Therapeutics Inc.’s shares? - US Post News

Oct 14, 2024